AROW vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

AROW

60.4
AI Score
VS
AROW Wins

CARE

59.8
AI Score

Investment Advisor Scores

AROW

Aug 23, 2026
60score
Recommendation
HOLD

CARE

Aug 23, 2026
60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AROW CARE Winner
Forward P/E 13.0039 13.6612 AROW
PEG Ratio 2.8438 0 Tie
Revenue Growth 4.6% 68.3% CARE
Earnings Growth 1.5% 253.9% CARE
Tradestie Score 60.4/100 59.8/100 AROW
Profit Margin 30.1% 44.9% CARE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AROW 1M: -1.7% · 3M: +4.7% CARE 1M: -7.8% · 3M: +16.0%

Current Technical Phase

AROW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.8 · Price: $38.48

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $31.25

Fundamentals Snapshot

Metric AROW CARE
Market Cap
Forward P/E 9.0 12.1
Trailing P/E 12.3 5.3
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.3% 0.6%
EPS 3.11 5.80
Dividend Yield 0.03% 0.00%

Frequently Asked Questions

Based on our detailed analysis, AROW is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.